SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SMX (Security Matters) Plc is a holding company, which engages in the provision of authentication solutions. It offers brand protection, authentication, and track and trace technology. The company was founded by Haggai Alon on July 1, 2022 and is headquartered in Dublin, Ireland.

SMX (Security Matters) Plc

SMX (Security Matters) PLC

SMX is trending as its announcement of a $250 million financing amendment, extending its capital runway to 2028, sparks intense debate; bullish traders anticipate a massive short squeeze reminiscent of past parabolic moves, while skeptics raise concerns about potential dilution from the equity line of credit.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is actively discussed as its newly inaugurated Eagle Line pilot production facility highlights its transition towards scalable solid-state battery manufacturing, driving community excitement for future OEM partnerships and impending updates on commercialization and revenue timelines.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is actively discussed as it navigates the fallout from retracting its compounded weight-loss pill following regulatory scrutiny and legal threats, with the community sharply divided between those foreseeing a significant short squeeze and a rebound based on its broader telehealth offerings, and others concerned about long-term brand damage and potential liabilities.

Rydex Investments - Invesco CurrencyShares British Pound Sterling Trust

Invesco CurrencyShares British Pound Sterling Trust

The Invesco CurrencyShares British Pound Sterling Trust is trending as recent cooler-than-expected UK CPI data has fueled aggressive market expectations for a Bank of England rate cut, driving bearish sentiment for the pound and highlighting central bank policy divergence.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as the recent departure of its CFO sparks community discussion regarding a potential acquisition, amidst persistent shareholder concerns over management and an upcoming European approval decision for Miplyffa.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is breaking out to new all-time highs, with the community actively discussing how escalating geopolitical tensions in the Middle East and Venezuela are creating a "war premium" on oil and driving significant capital rotation into the energy sector.

Zeta Global Holdings Corp. operates as a marketing technology software company, which engages in the provision of enterprises with consumer intelligence and marketing automation software. It enables its customers to target, connect and engage consumers through software that delivers marketing across all addressable channels, including email, social media, web chat, connected TV and video among others. The company was founded by David A. Steinberg and John Sculley on May 9, 2012 and is headquartered in New York, NY.

Zeta Global Holdings Corp - Ordinary Shares - Class A

Zeta Global Holdings Corp

ZETA is trending with significant anticipation surrounding its impending earnings, which many expect to be an 18th consecutive beat-and-raise, as the community actively discusses its robust free cash flow and AI-driven Athena platform as undervalued strengths despite recent market volatility.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is actively discussed after projecting its first-ever quarterly operating profit for Q4 2025 and achieving 100 million battery swaps, with bulls expecting a significant re-rating driven by these milestones and its battery swap "moat," while some in the community remain skeptical of sustained profitability, fearing dilution and citing ongoing market manipulation.

VanEck ETF Trust - VanEck Junior Gold Miners ETF

VanEck Junior Gold Miners ETF

The VanEck Junior Gold Miners ETF (GDXJ) is trending as gold and silver prices push toward new highs, with gold reclaiming $5,000/oz and silver seeing significant gains. While many in the community remain bullish on junior miners as a hedge against global uncertainty and stagflation, active debate centers on the ETF's lagging performance relative to soaring metal prices, fueling discussions of an imminent catch-up rally or a potential pullback.

Baidu, Inc. engages in the provision of internet search and online marketing solutions. The firm’s products and services include Baidu App, Baidu Search, Baidu Feed, Haokan, Quanmin, Baidu Post Bar, Baidu Knows, Baidu Encyclopedia, Baidu Input Method Editor or Baidu IME, Baidu AI Cloud and Overseas Products. It operates through the following segments: Baidu Core and iQIYI. The Baidu Core segment provides search-based, feed-based, and other online marketing services. The iQiyi segment is an online entertainment service provider, which offers original, professionally produced and partner-generated content on its platform. The company was founded by Yanhong Li and Xu Yong on January 18, 2000 and is headquartered in Beijing, China.

Baidu Inc - ADR

Baidu is gaining significant investor attention after announcing a $5 billion share buyback and its first-ever dividend, alongside the confidential Hong Kong IPO filing for its AI chip unit, Kunlunxin, sparking community discussions about unlocking substantial value in its AI and autonomous driving segments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Editas Medicine (NASDAQ:EDIT) Share Price Crosses Below 50 Day Moving Average - Here's What Happened

Editas Medicine (NASDAQ:EDIT) Stock Crosses Below 50 Day Moving Average - What's Next...

Editas Medicine (NASDAQ:EDIT) Stock Crosses Below 50 Day Moving Average - What's Next?

Editas Medicine (NASDAQ:EDIT) Share Price Passes Below 50-Day Moving Average - What's Next...

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six brokerages that are currently covering the company, MarketBeat.com...

Cathie Wood shells out $1.3 million on biotech stock

On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics (NTLA), scooping up 145,153 shares in the gene-editing play. For the most part, it...

Editas Medicine (NASDAQ:EDIT) Stock Price Down 2.9% - Should You Sell?

Editas Medicine (NASDAQ:EDIT) Shares Down 2.9% - Should You Sell...

Editas (EDIT) Down 8.3% Since Last Earnings Report: Can It Rebound?

Editas (EDIT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Consensus Recommendation of "Hold" from Analysts

Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) has been given an average rating of "Hold" by the twelve ratings firms that are currently covering the company, Marketbeat reports. Two equities...

Editas Medicine (NASDAQ:EDIT) CEO Sells $12,046.45 in Stock

Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) CEO Gilmore Neil O'neill sold 5,603 shares of the business's stock in a transaction that occurred on Wednesday, December 3rd. The stock was sold...

Insider Selling: Editas Medicine (NASDAQ:EDIT) CEO Sells 5,603 Shares of Stock

Editas Medicine, Inc. (NASDAQ:EDIT - Get Free Report) CEO Gilmore Neil O'neill sold 5,603 shares of the stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of...

Editas Medicine (NASDAQ:EDIT) Shares Cross Below 50-Day Moving Average - Time to Sell?

Editas Medicine (NASDAQ:EDIT) Shares Cross Below Fifty Day Moving Average - Should You Sell...

Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA.

Editas Medicine Inc

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

What will be the S&amp;P 500’s next 5% move?

Stocktwits

What will be the S&P 500’s next 5% move?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.23	--	--	N/A
Q3 '25	-$0.30	-$0.28	5.45%	BEAT
Q2 '25	-$0.39	-$0.63	-61.31%	MISSED
Q1 '25	-$0.56	-$0.92	-63.13%	MISSED
Q4 '24	-$0.38	-$0.55	-45.75%	MISSED

EDIT
Editas Medicine Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest EDIT News

EDITEditas Medicine Inc